RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Shiramizu, Bruce
PropertyValue
overview Dr. Shiramizu is a Professor in the Departments of Pediatrics and Tropical Medicine, Medical Microbiology, & Pharmacology at the University of Hawaii (UH) John A. Burns School of Medicine (JABSOM). As a pediatric Hem/Onc physician, he has 20+ years clinical translational research experience at JABSOM (18 years). His pediatric clinical research experience includes being a member of the Children’s Oncology Group Non-Hodgkin Lymphoma (NHL) Committee and active in clinical trial study protocol development and implementation since 1993 (Children’s Cancer Group, Pediatric Oncology Group, Children’s Oncology Group). He has experience as PI and multiple-PI for adult and pediatric clinical studies locally and nationally, with involvement in study design, development, implementation, and coordination. He has extensive experience with mentoring students and faculty. His other area of research include HIV-associated co-morbidities (cognition, cancer) and childhood non-Hodgkin lymphoma. He collaborates with RCMI investigators across RTRN.
One or more keywords matched the following items that are connected to Shiramizu, Bruce
Item TypeName
Academic Article Possible Mitochondria-Associated Enzymatic Role in Non-Hodgkin Lymphoma Residual Disease.
Academic Article Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.
Academic Article Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.
Academic Article Effective use of small-interfering RNA to characterize residual B-cell non-Hodgkin lymphoma cells following chemotherapy.
Academic Article Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma.
Academic Article Paediatric non-Hodgkin lymphoma - perspectives in translational biology.
Academic Article Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
Academic Article Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers.
Academic Article Pathogenesis of HIV-associated non-Hodgkin lymphoma.
Academic Article Absence of human herpesvirus-6 genome by polymerase chain reaction in children with Hodgkin disease: a Children's Cancer Group Lymphoma Biology Study.
Academic Article Assessing immunoglobulin heavy chain rearrangements in pediatric CD20-positive and CD20-negative classic Hodgkin's disease.
Academic Article Chemotoxicity recovery of mitochondria in non-Hodgkin lymphoma resulting in minimal residual disease.
Academic Article A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Concept Hodgkin Disease
Grant INTEGRATED HIV AND AIDS T CELL LYMPHOMAS
Grant Real-time Minimal Residual Disease assay of Pediatric B-Cell Non-Hodgkin Lymphoma
Academic Article Raman-Enhanced Spectroscopy (RESpect) Probe for Childhood Non-Hodgkin Lymphoma.
Search Criteria
  • Hodgkin Disease
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support